Alex Xu

Alex Xu

Company: NMPA

Job title: Principle Scientist


Dr. Xu is currently working in the Center of Drug Evaluation (CDE), Chinese Food and Drug Administration (CFDA), as a chief scientist. Prior to this appointment, he had worked as a senior Pharmacologist/Toxicologist in the Office of New Drugs (OND) at US Food and Drug Administration, Center for Drug Evaluation and Research (US FDA/CDER) since 2006. Before joining FDA, he worked as a senior scientist in pharmacogenomics and toxicogenomics in Gene Logic Ltd. Dr. Xu received a Master degree in pathology and PhD degree in pharmacology and toxicology from the University of Arkansas for Medical Sciences after he graduated from Shandong Medical University in China. He completed his PhD research project in Duke University and had his postdoctoral training in the National Center for Toxicological Research (NCTR). He is a Diplomate of American Board of Toxicology (DABT) since 2005. He is a full member of Society of Toxicology (SOT) and the immediate past president of the American Association of Chinese in Toxicology (AACT). Dr. Xu is also an adjunct professor of Beijing University, Shanghai Jiao Tong University, and Zhejiang University.


Addressing Regulatory Considerations for ADCs & How the NMPA Reform Affects Regulations 5:10 pm

Read more

day: Day One

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.